Abstract: A protection device for monitoring an energy supply grid has a measured value acquisition device for acquiring measured values which indicate an electrical state of the energy supply grid, and an evaluation device which is connected to the measured value acquisition device and is configured to carry out a plurality of protection functions and, as a result, to make a decision as to whether the energy supply grid is in a permissible or impermissible operating state. Here, the evaluation device be designed entirely in the form of a single neural network with an input neuron layer that receives the measured values and/or values derived therefrom, intermediate neuron layers, and an output neuron layer which outputs a classification of operating states of the energy supply grid. The neural network for classifying the operating states is trained to carry out all protection functions together.

Abstract: An apparatus and method providing a processed audio signal from an input audio signal, wherein the apparatus is configured to process a noise signal, or a signal derived from the noise signal, using one or more flow blocks, in order to obtain the processed audio signal, wherein the apparatus is configured to adapt a processing performed using the one or more flow blocks in dependence on the input audio signal and using a neural network. An apparatus also provides neural network parameters for an audio processing, wherein the apparatus is configured to process a training audio signal, or a processed version thereof, using one or more flow blocks in order to obtain a training result signal, wherein the apparatus is configured to adapt a processing performed using the one or more flow blocks in dependence on a distorted version of the training audio signal and using a neural network.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analog, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Abstract: The invention relates to an oil control ring for pistons of internal combustion engines. The aim of the invention is to provide an improved shape-adaptation capacity in comparison to prior art, with a tangential force that enables the ring to guarantee low friction and also low oil consumption during the operation of the engine. To achieve this, the inventive oil control ring comprises a solid bearing surface that lies against the cylinder wall, in addition to parallel ring flanks, between which a radial recess that runs around the periphery is configured in the rear of the ring, said recess being designed to receive a coil spring. The peripheral region of the ring flanks is provided with undulating end faces that face towards the rear of the ring. Said undulating end faces of the upper and lower ring flanks are offset out of phase with one another.

Abstract: The invention relates to an oil control ring (10) for pistons of internal combustion engines. The aim of the invention is to provide an improved shape-adaptation capacity in comparison to prior art, with a tangential force that enables the ring to guarantee low friction and also low oil consumption during the operation of the engine. To achieve this, the inventive oil control ring comprises a solid bearing surface (13) that lies against the cylinder wall, in addition to parallel ring flanks (11a, 11c), between which a radial recess (12a) that runs around the periphery is configured in the rear (12) of the ring, said recess being designed to receive a coil spring (M). The peripheral region of the ring flanks is provided with undulating end faces (12b, 12c) that face towards the rear of the ring. Said undulating end faces (12b, 12c) of the upper and lower ring flanks (11a, 11c) are offset out of phase with one another.